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Helicobacter pylorus (HP) is a Gram-negative spiral-shaped microaerophilic
bacterium, which colonized in the gastric mucosa of humans.
1 HP infection is a
worldwide pathogenic condition in the development of infection, causing
different problems in the gastric mucosa.
2 In addition, some chronic infections,
acquired early in life, confer an increased risk of gastric cancer
.3,4 Although more
than 50% of the human population are infected with H. pylori, only a subset
develops disease. This is considered to be due to both pathogen-inherent virulence
factors and the type and intensity of the oxidative stress that is induced by the
inflammation.
5
It has been convincingly demonstrated that HP-induced mucosal inflammation
is accompanied by formation of reactive oxygen species (ROS) by the invading
polymorphonuclear cells and macrophages. However, free oxygen radicals, like
superoxide, do not cause any major oxidative damage to the gastric epithelium per
se.
6 The severity of active inflammation of HP (+) gastritis has been shown to be
directly correlated to the presence of high concentrations of free radicals which
disappear completely with resolution of active inflammation after eradication.
7,8
Free radicals, however, do not provoke oxidative damage on the gastric epithelium
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directly, but through the formation of peroxinitrite,
9 and the
levels of nitrotyrosine, a specific marker of peroxinitrite,
10
have been reported to be significantly higher in patients
with HP (+) gastritis than in those with HP (-) gastritis.
11,12
Oxidative stress causes damage to important biological
structures such as proteins, carbohydrates, lipids and nucleic
acids, and may enhance inflammatory response. New
compounds and modified structures are formed, and one of
them is advanced oxidation protein products (AOPP).
13
Plasma AOPP concentrations may be a useful marker in
protein oxidative damage, measuring highly oxidized
proteins, especially albumin.
14 Neutrophils are considered
to be major effectors cells in the tissue damage that occurs
in inflammatory disease. One of the major granule proteins
is the enzyme myeloperoxidase (MPO), a heme protein
that accounts for 5% of the total neutrophil protein.
15 The
release of ROS by neutrophils may result in lipid and
protein peroxidation, but protein oxidation has not been
extensively studied in clinical settings.
16 An antioxidant
enzyme catalase (CAT) is located in peroxisomes, and
decomposes hydrogen peroxide to water and oxygen.
17
The aim of the present study was to investigate and
compare the serum enzyme protein levels of MPO, CAT,
and AOPP in patients with gastric cancer and Anti-HP IgG
antibody positive non-gastric cancer controls. This study is
the first report to describe an association between protein
oxidation and H. pylori infected patients.
The thirty patients with gastric cancer (12 female, 18 male;
range, 38-83 years) were included in the study as group 1,
and Anti-HP IgG antibody test was detected as positive in
50% (15/30) of patients with carcinoma. All of the patients
in this group underwent upper gastrointestinal endoscopies
because of various indications (dyspeptic symptoms,
recurrent abdominal pain, and chronic vomiting). Routine
regular biopsies (duodenum, antrum, corpus, and esoph-
agus) were collected, and the diagnosis of gastric cancer
was made by histopathological examination. Histopath-
ology showed adenocarsinoma in 28 samples (93%) and
lymphoma in 2 (7%) of group 1. Of the 28 adenocar-
sinoma, 8 were classified as intestinal (7 male and 1
female; mean age 53.25 years, range 45-66 years), and 3 as
diffuse (2 male and 1 female; mean age 44.33 years, range
38-53 years). The other 17 samples were reported as
adenocarcinoma (7 male and 10 female; mean age 63.77
years, range 46-83 years). 
The control group also included 30 subjects (18 female
and 12 male, range; 32-65 years) and all of the subjects had
positive Anti-HP IgG antibody (group 2). Exclusion criteria
included subjects who had been taking other drugs, known
drug allergy to the study drugs, gastric cancer, gastro
duodenal ulcer, liver cirrhosis, renal failure, severe concomi-
tant disease, pregnancy, or lactation and previous gastric sur-
gery in group 2. The institutional ethics committee approved
the study and all participants gave written informed consent.
Venous blood samples were obtained from all patients to
measure the levels of AOPP, MPO, CAT, and other bioche-
mical parameters. The tubes were centrifuged for 10 min at
3,000 r.p.m and all samples were stored at -70˚C until
analyzed.
An anti-HP IgG antibody test, ELISA (R-Biopharm AG,
Germany), was conducted for detecting HP-infected par-
ticipants.
Determination of AOPP was based on a spectropho-
tometric assay according to Witko-Sarsat, et al.
18 AOPP
levels were expressed in µmol of chloramine-T equivalents
per litre of serum (µmol/L).
Serum MPO activity was determined by the method of
Bradley et al.,
19 and was based on kinetic measurement of
the formation rate of the yellowish-orange product of the
oxidation of o-dianisidne with MPO in the presence of
hydrogen peroxide (H2O2) at 460 nm. One unit of MPO was
defined as that degrading 1 µmol of H2O2 per minute at
25˚C. A molar extinction coefficient of 1.3×10
4 M
-1 cm
-1 of
oxidized 0-dianisidine was used for the calculation. MPO
activity was expressed in units per liter of plasma (U/L).
The serum CAT activity was determined by Goth’s
colorimetric method,
20 in which serum was incubated with
H2O2, and the enzyme reactions were stopped by the
addition of ammonium molybdate. Serum CAT activity
was expressed as kU/L.
Biochemical measurements were performed using a
Hitachi PP Modular Automatic analyzer (Tokyo, Japan)
with Roche original reagents. CRP level was measured by
nepholometric method using Cardio Phase hs CRP reagents
(Dade Behring), and hematological parameters were also
evaluated in the both groups using Coulter (USA) auto-
mated cell counter.
Statistical analysis
The results are expressed as mean (X) ± standard error
(SE). Kolmogorov-Smirnov normality test was applied for
all variables. Then, groups of data (both subgroups in
group 1 and groups 1-2) were compared with an analysis
of independent student’s t test.
Mean age of the group 1 was significantly higher than that in
group 2 (58.12 ± 1.92, 44.32 ± 1.44, respectively) (p< 0.01). 
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Significantly increased AOOP level was found in group
1 as compared to group 2 (Means of the groups are 93.26
± 8.01 and 59.52 ± 4.82 µmol/L, respectively) (p < 0.05).
Activities of MPO (group 1: 116.85 ± 9.88, group 2: 114.58
± 7.63 U/L) and CAT (group 1: 147.96 ± 21.83, group 2:
122.84 ± 13.05 kU/L) were found statistically insignificant
between the groups. In addition, AOPP level [Anti-HP IgG
(+): 97.08 ± 8.75, Anti-HP IgG(-): 89.44  ± 7.98 µmol/L),
MPO (Anti-HP IgG (+): 126.38 ± 10.08, Anti-HP IgG (-):
106.59 ± 17.45 U/L] and CAT [Anti-HP IgG (+): 131.53 ±
24.95, Anti-HP IgG (-): 165.65 ± 36.97 kU/L] activities
were similar between the Anti-HP IgG positive and
negative subgroups of group 1 patients. Both the Spearman
rank correlation (p = 0.711, r = -0.078) and analyse of
variance (ANOVA) (F = 0.002, p = 0.964) showed no signi-
ficant relationship between the stage and AOPP levels in
group 1.
However, significantly increased AST, and ALT activi-
ties, urea, CRP, and neutrophil levels, and decreased
protein, albumin, hemoglobin, and lymphocyte levels were
also found in group 1, compared to group 2.
Although the association between HP colonization and
gastric noncardia adenocarcinoma is strong, estimates of
the magnitude of the association vary, presumably because
of differences in study design, length of follow-up, patient
age at diagnosis, histologic subtype of cancer, HP strain,
and host characteristics.
21
During the process of colonizing the host, HP induces a
strong inflammatory response from host cells infiltrated.
This defense is mediated by neutrophils and macrophages,
culminating in generation of large amounts of ROS, which
is presented to the persistent pathogen. Production of ROS
by gastric cells,
22 and phagocytes induced by HP has been
shown in vitro, and increased levels of ROS in the gastric
mucosa have been measured in HP-infected patients.
23,24
Wang, et al.
25 reported that the accumulation of lipid pero-
xides in HP cells could be one of the major outcomes of
oxidative stress imposed by the host. It is well known that
lipid peroxidation contributes to cell injury by altering the
DISCUSSION
Table 2.Levels of AOPP and Activities of MPO and CAT of the Subjects Included in the Study
Parameters
Group 1 (X ± SE) Group 2 (X ± SE)
IgG (+) (n = 15) IgG (-) (n = 15) Total (n = 30) (n = 30)
AOPP (µmol/L) 97.08 ± 8.75 89.44 ± 7.98 93.26 ± 8.01* 59.52 ± 4.82 
MPO (U/L) 126.38 ± 10.08 106.59 ± 17.45 116.85 ± 9.88 114.58 ± 7.63
CAT (kU/L) 131.53 ± 24.95 165.65 ± 36.97 147.96 ± 21.82 122.84 ± 13.05 
Significant different as compared to group 2.
*p< 0.05.
Table 1. Biochemical and Hematological Features of the Subjects Included in the Study
Parameters
Group 1 (X ± SE) Group 2 (X ± SE)
IgG (+) (n = 15) IgG (-) (n = 15) Total (n = 30) (n = 30)
Glucose (mg/dL) 98.0 ± 6.70 98.11 ± 7.05 98.04 ± 4.82 89.82 ± 4.13
AST (U/L) 37.0 ± 11.85 33.11 ± 7.79 35.54 ± 7.84* 19.68 ± 0.81
ALT (U/L) 24.93 ± 4.84 32.44 ± 9.72 27.75 ± 4.67* 16.51 ± 0.83
Urea (mg/dL) 40.86 ± 4.65 35.75 ± 6.96 39.08 ± 3.82* 29.32 ± 1.51
Creatinine (mg/dL) 1.02 ± 0.28 0.81 ± 0.07 0.94 ± 0.18 0.73 ± 0.03
LDH (U/L) 634.78 ± 182.14 511.0 ± 97.65 597.65 ± 129.66 373.36 ± 16.04
T. protein (g/dL) 6.25 ± 0.25 6.55 ± 0.23 6.37 ± 0.17
� 7.59 ± 0.09
Albumine (g/dL) 3.19 ± 0.16 3.45 ± 0.19 3.30 ± 0.12
� 4.55 ± 0.08
Uric acid (mg/dL) 3.87 ± 0.80 4.51 ± 0.65 4.10 ± 0.12  4.50 ± 0.29
WBC (×10
9/L) 8.34 ± 0.76 7.88 ± 0.59 8.15 ± 0.50 8.07 ± 0.45
HB (g/dL) 10.81 ± 0.68 10.73 ± 0.58 10.78 ± 0.45* 15.37 ± 1.54
CRP (mg/L) 46.09 ± 25.4 57.42 ± 18.84 52.46 ± 14.88
� 4.09 ± 0.94
Neutrophil (%) 70.90 ± 2.74 72.15 ± 3.56 71.45 ± 2.1
� 56.73 ± 2.58
Lymphocyte (%) 20.45 ± 2.44 16.98 ± 2.94 18.92 ± 1.88
� 30.17 ± 2.45
Significant different as compared to group 2.
*p< 0.05. 
�p< 0.01.Tevfik Noyan, et al.
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basic physical properties and structural organization of
membrane components.
26 Unsaturated fatty acids are rarely
produced in H. pylori cells, but they can be taken up from
the environment.
27 The growth of HP displays added
sensitivity to unsaturated free fatty acids due to their
incorporation into phospholipids of the membrane, leading
to membrane dysfunction.
28 The lipid hydroperoxide
(LOOH), lipid radical, epoxyllylic peroxyl radical, and
peroxyl radicals are the intermediates products of free
radical chain reaction and these radicals are considered to
be highly genotoxic.
29 It was also reported that at least two
enzymes of the Prx family in H. pylori have activity in
reducing LOOH: an alkyl hydroperoxide reductase (AhpC)
and a bacterioferritin-comigratory protein (BCP). Both
proteins play significant roles in resisting oxidative stress
and contribute to the efficient colonization of the host,
suggesting that prevention of lipid peroxidation may be
important for HP in vivo survival.
30 It is well documented
that both AhpC and BCP confer protection from unsatu-
rated fatty acids-mediated toxicity, and that the mutant
cells defective in AhpC, BCP, or in both enzymes contain
increased amounts of LOOH. The source of lipid peroxi-
dation is probably the unsaturated fatty acids in the blood-
based medium for growth of HP cells.
29 Recent studies
have also shown that the oxidative stress response of HP is
much more vast, adaptable, and interconnected than pre-
viously appreciated. Furthermore, mutations affecting
almost all of these newly described enzymes appear to be
as important for survival in the host as the well-studied
traditional oxidative stress combating enzymes like CAT
and superoxide dismutase (SOD).
31
Gastric carcinoma is one of the most common neoplasms
in the world, and most are adenocarcinomas. According to
the Lauren classification, two epidemiologically distinct
types exist. Intestinal-type carcinoma (tubular carcinoma,
TC) is associated with HP infection, chronic gastritis,
atrophy, intestinal metaplasia, and dysplasia that evolve as
a multi-step process into this type of cancer. Diffuse-type
carcinoma, which occurs more often in younger patients, is
also associated with HP infection, but not with atrophy and
intestinal metaplasia, and is associated with a worse
prognosis. Mixed polymorphous carcinoma encompasses
tumors showing both glandular and diffuse components.
32
Although approximately half of the world population is
infected with HP, a cancerous outcome of infection is very
rare. The reasons for this phenomenon are unknown.
Gastric cancer is usually diagnosed after the 5th decade of
life, but HP infection usually occurs in childhood and
remains active lifelong unless treated. A cohort study has
shown a link between early infection and increased cancer
risk.
2,33 In the present study, the level of AOOP was in-
creased significantly in the gastric cancer patients as com-
pared with non-gastric cancer patients. However, there
were no significant differences between the Anti-HP IgG
positive and negative patients with gastric cancer. The
subjects with gastric cancer had advanced clinical stage of
disease (27% in stage 2, and 73% in stage 3) in this study.
And, there was no significant correlation between the
AOPP levels and clinical stages of gastric cancer. To our
best knowledge, this is the first study that investigated the
AOPP levels in patients with HP. Oxidative stress has been
suggested to play a major role in carcinogenesis, but the
mechanisms involved still remain unclear.
32 Spontaneous
non-enzymatic modifications of protein are commonly
reported in tissues with slow turnover and they are consi-
dered by several authors as a possible common mechanism
involved in the progression of many pathological condi-
tions.
34 Among the non-enzymatic processes, oxidative
stress and glycation have aroused a particular interest in
recent years.
35 It was also recently demonstrated that lipid
peroxides per se can enhance the process of protein glyca-
tion.
36 Biochemical effects of free radicals also include
oxidative modification of proteins,
37 however, protein
oxidation has not been extensively studied in clinical
settings until recent years because of lack of easily acces-
sible methods to detect protein damage. The observed
increase in plasma AOPP levels in patients with gastric
cancer which is seemingly associated with cellular damage
resulting from reactive oxygen metabolites includes lipid
peroxidation, protein oxidation, and oxidative DNA dam-
age. All of these oxidative products can result in bioche-
mical changes, leading to cancer. A positive association
has been demonstrated between HP infection and gastric
adenocarcinoma with increased oxidative stress.
38 There-
fore, we think that appropriate treatment to reduce oxidative
stress would be expected to prevent subsequent gastric
carcinogenesis through lessening HP-associated inflam-
mation.
Myeloperoxidase is a lysosomal enzyme in polymor-
phonuclear leukocytes and monocytes, and produces
hypochlorous acid which has microbicidal activity against
a wide range of organisms, resulting in tissue inflamma-
tion. It was shown that water extract of HP can activate
neutrophils and enhance the secretion of MPO.
39 CAT is a
ubiquitous, well-studied enzyme that catalyses the decom-
position of hydrogen peroxide (H2O2) into water and
oxygen to protect cells from the damaging effects of
H2O2.
24 HP has been shown to produce CAT, but the
reported amount of this enzyme secreted would not be
sufficient to scavenge extra cellular oxidants.
40 Almost all
the previous studies on the association of with HP in adult
population were performed in gastric mucosa.
12,21,23 Some
previous studies have reported that no CAT activity was
found in most gastric juices, probably because of their lowpH levels, and in some antral tissue specimens.
41,42 Akcan,
et al.
2 reported no unchanged of MPO and SOD activity in
gastric mucosa of childhood period with HP (+) and (-)
subjects, and Bulbuloglu, et al.
42 also reported no unchanged
of CAT activity in antral mucosal between HP (+) and (-)
subjects. In the present study, MPO and CAT activities
were similar between the subjects included in the study.
There are varying results on antioxidant enzyme activities
in patients with gastric cancer.
43-45 However, recent results
are similar to present result. Al-Shukaili, et al.
43 reported
that no change of MPO activity in the serum of patients
with gastric cancer compared to healthy controls. Dursun,
et al.
44  reported decreased CAT activity in patients with
esophageal and gastric cancer compared with controls.
However, Dincer, et al.
46 reported decreased glutathione
peroxidase (GSH-Px) and increased SOD activity in
gastric cancer patients when compared to healthy subjects.
Generally, antioxidants are involved directly in the conver-
sion of ROS to less-reactive species, however, antioxidant
protection therapy against free radicals should be used with
caution since its effects depend on the stage at which it is
introduced. When used during the progression stage of
cancer, it might actually stimulate growth of tumors through
enhanced survival of tumor cells. Another important issue
which should be taken into consideration is a pro-oxidant
character of some antioxidants which may occur depend-
ing on the concentration and environment (oxygen pres-
sure) in which they act.
47 Therefore, further investigations
are needed to elucidate the importance of antioxidant
enzymes in gastric cancer patients. 
In conclusion, the results of our study showed that gas-
tric cancer patients revealed increased protein oxidation.
However, myeloperoxidase and catalase activities in gastric
cancer patients were not different from those in H. pylori
IgG positive non-gastric cancer subjects. However, further
clinical studies are necessary to explain the relationship
between protein oxidation and antioxidant enzymes activi-
ties in gastric cancer and H. pylori infection.
1.Godlewska R, Dzwonek A, Miku a M, Ostrowski J, Paw owski
M, Bujnicki JM, et al. Helicobacter pylori protein oxidation inf-
luences the colonization process. Int J Med Microbiol 2006;296:
321-4.
2. Akcam M, Elmas O, Yilmaz A, Ca  lar S, Artan R, Gelen T, et al.
Myeloperoxidase, xanthine oxidase and superoxide dismutase in
the gastric mucosa of Helicobacter pylori positive and negative
pediatric patients. Mol Cell Biochem 2006;290:125-30. 
3. Nardone G, Morgner A. Helicobacter pylori and gastric mali-
gnancies. Helicobacter 2003;8 Suppl 1:44-52.
4. Isakov V, Malfertheiner P. Helicobacter pylori and nonmalignant
diseases. Helicobacter 2003;8 Suppl 1:36-43.
5. Tummala S, Keates S, Kelly CP. Update on the immunologic
basis of Helicobacter pylori gastritis. Curr Opin Gastroenterol
2004;20:592-7.
6. Elfvin A, Bölin I, Lönroth F, Fändriks L. Gastric expression of
inducible nitric oxide synthase and myeloperoxidase in relation to
nitrotyrosine in Helicobacter pylori-infected Mongolian gerbils.
Scand J Gastroenterol 2006;41:1013-8.
7. Farkas R, Selmeci L, Tulassay Z, Pronai L. Superoxide-dismutase
activity of the gastric mucosa in patients with Helicobacter pylori
infection. Anticancer Res 2003;23:4309-12. 
8. Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M,
Diezi J, et al. Oxidative stress in gastric mucosa of asymptomatic
humans infected with Helicobacter pylori: effect of bacterial
eradication. Helicobacter 2002;7:342-8.
9. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA.
Apparent hydroxyl radical production by peroxynitrite: implica-
tions for endothelial injury from nitric oxide and superoxide. Proc
Natl Acad Sci U S A 1990;87:1620-4. 
10. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a
biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;
411:157-60.
11. Kimura A, Tsuji S, Tsujii M, Sawaoka H, Iijima H, Kawai N, et
al. Expression of cyclooxygenase-2 and nitrotyrosine in human
gastric mucosa before and after Helicobacter pylori eradication.
Prostaglandins Leukot Essent Fatty Acids 2000;63:315-22. 
12. Sakaguchi AA, Miura S, Takeuchi T, Hokari R, Mizumori M,
Yoshida H, et al. Increased expression of inducible nitric oxide
synthase and peroxynitrite in Helicobacter pylori gastric ulcer.
Free Radic Biol Med 1999;27:781-9.
13. Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J.
Advanced glycoxidation end products in chronic diseases-clinical
chemistry and genetic background. Mutat Res 2005;579:37-46.
14. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drüeke T,
Santangelo F, et al. AOPP-induced activation of human neutro-
phil and monocyte oxidative metabolism: a potential target for N-
acetylcysteine treatment in dialysis patients. Kidney Int 2003;64:
82-91.
15. Pullar JM, Vissers MC, Winterbourn CC. Living with a killer: the
effects of hypochlorous acid on mammalian cells. IUBMB Life
2000;50:259-66.
16. Matteucci E, Biasci E, Giampietro O. Advanced oxidation pro-
tein products in plasma: stability during storage and correlation
with other clinical characteristics. Acta Diabetol 2001;38:187-9.
17. Winterbourn CC. Superoxide as an intracellular radical sink. Free
Radic Biol Med 1993;14:85-90.
18. Witko-Sarsat V, Friedlander M, Capeillére-Blandin C, Nguyen-
Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein
products as a novel marker of oxidative stress in uremia. Kidney
Int 1996;49:1304-13.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Mea-
surement of cutaneous inflammation: estimation of neutrophil
content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
20. Góth L. A simple method for determination of serum catalase
activity and revision of reference range. Clin Chim Acta 1991;
196:143-51.
21. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen
P, Newschaffer CJ, et al. Opposing risks of gastric cardia and
noncardia gastric adenocarcinomas associated with Helicobacter
pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52.
H. pylori and Oxidative Stress
Yonsei Med J   http://www.eymj.org    Volume 50   Number 5   October 2009 681
REFERENCES
l lTevfik Noyan, et al.
Yonsei Med J   http://www.eymj.org    Volume 50   Number 5   October 2009 682
22. Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxy-
gen species by gastric cells in association with Helicobacter
pylori. Free Radic Res 1996;24:439-50.
23. Ramarao N, Gray-Owen SD, Meyer TF. Helicobacter pylori
induces but survives the extracellular release of oxygen radicals
from professional phagocytes using its catalase activity. Mol
Microbiol 2000;38:103-13.
24. Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, et al.
Increased oxidative DNA damage in Helicobacter pylori-infected
human gastric mucosa. Cancer Res 1996;56:1279-82.
25. Wang G, Conover RC, Benoit S, Olczak AA, Olson JW, Johnson
MK, et al. Role of a bacterial organic hydroperoxide detoxification
system in preventing catalase inactivation. J Biol Chem 2004;
279:51908-14.
26. Jacob RF, Mason RP. Lipid peroxidation induces cholesterol
domain formation in model membranes. J Biol Chem 2005;
280:39380-7.
27. Scherer C, Müller KD, Rath PM, Ansorg RA. Influence of
culture conditions on the fatty acid profiles of laboratory-adapted
and freshly isolated strains of Helicobacter pylori. J Clin Micro-
biol 2003;41:1114-7.
28. Sun CQ, O’Connor CJ, Roberton AM. Antibacterial actions of
fatty acids and monoglycerides against Helicobacter pylori.
FEMS Immunol Med Microbiol 2003;36:9-17.
29. Wang G, Hong Y, Johnson MK, Maier RJ. Lipid peroxidation as
a source of oxidative damage in Helicobacter pylori: protective
roles of peroxiredoxins. Biochim Biophys Acta 2006;1760:1596-
603.
30. Wang G, Olczak AA, Walton JP, Maier RJ. Contribution of the
Helicobacter pylori thiol peroxidase bacterioferritin comigratory
protein to oxidative stress resistance and host colonization. Infect
Immun 2005;73:378-84.
31. Wang G, Alamuri P, Maier RJ. The diverse antioxidant systems
of Helicobacter pylori. Mol Microbiol 2006;61:847-60.
32. Bancel B, Esteve J, Souquet JC, Toyokuni S, Ohshima H, Pigna-
telli B. Differences in oxidative stress dependence between gastric
adenocarcinoma subtypes. World J Gastroenterol 2006;12:1005-12.
33. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Heli-
cobacter pylori infection and gastric carcinoma, gastric ulcer, and
duodenal ulcer risk. Cancer Res 1995;55:562-5.
34. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Ran-
domized placebo-controlled trial of Helicobacter pylori eradication
for iron-deficiency anemia in preadolescent children and ado-
lescents. Helicobacter 1999;4:135-9.
35. Vijayan G, Sundaram RC, Bobby Z, Hamide A, Selvaraj N,
Dasse NR. Increased plasma malondialdehyde and fructosamine
in anemic H pylori infected patients: effect of treatment. World J
Gastroenterol 2007;13:796-800.
36. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides
and antioxidants on glycation of hemoglobin: an in vitro study on
human erythrocytes. Clin Chim Acta 2006;366:190-5.
37. Davies KJ. Protein damage and degradation by oxygen radicals.
I. general aspects. J Biol Chem 1987;262:9895-901.
38. Park S, Kim WS, Choi UJ, Han SU, Kim YS, Kim YB, et al.
Amelioration of oxidative stress with ensuing inflammation
contributes to chemoprevention of H. Pylori-associated gastric
carcinogenesis. Antioxid Redox Signal 2004;6:549-60.
39. Takemura T, Granger DN, Evans DJ Jr, Evans DG, Graham DY,
Anderson DC, et al. Extract of Helicobacter pylori induces neu-
trophils to injure endothelial cells and contains antielastase
activity. Gastroenterology 1996;110:21-9.
40. Mori M, Suziki H, Suzuki M, Kai A, Miura S, Ishii H. Catalase
and superoxide dimutase secreted from Helicobacter pylori.
Helicobacter 1997;2:100-5. 
41. Durak I, Ormeci N, Akyol O, Canbolat O, Kavutçu M, Bulbül M.
Adenosine deaminase, 5’-nucleotidase, xanthine oxidase, super-
oxide dismutase, and catalase activities in gastric juices from
patients with gastric cancer, ulcer, and atrophic gastritis. Dig Dis
Sci 1994;39:721-8. 
42. Bulbuloglu E, Inanc F, Bakaris S, Kantarceken B, Cetinkaya A,
Ca lar R, et al. Association of adenosine deaminase, superoxide
dismutase, and catalase activities with Helicobacter pylori. Dig
Dis Sci 2005;50:2296-9.
43. Al-Shukaili A, Al-Jabri AA, Al- Moundhri MS. Prognostic value
of auto-antibodies in the serum of Omani patients with gastric
cancer. Saudi Med J 2006;27:1873-7.
44. Dursun H, Bilici M, Uyanik A, Okcu N, Akyüz M. Antioxidant
enzyme activities and lipid peroxidation levels in erythrocytes of
patients with oesophageal and gastric cancer. J Int Med Res 2006;
34:193-9.
45. Starzynska T, Malfertheiner P. Helicobacter and digestive mali-
gnancies. Helicobacter 2006;11:32-5. 
46. Dincer Y, Himmetoglu S, Akcay T, Ersoy EY, Gunes KN,
Tortum O. Prognostic significances of oxidative DNA damage
evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzy-
mes in patients undergoing resection of gastric and colon carci-
noma. Neoplasma 2007;54:131-6.
47. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free
radicals, metals and antioxidants in oxidative stress-induced
cancer. Chem Biol Interact 2006;160:1-40. 
̃